期刊文献+

真性红细胞增多症合并溶血1例报告并文献复习 被引量:1

下载PDF
导出
摘要 真性红细胞增多症是由于多能造血干细胞克隆异常,导致红细胞异常增殖为主的慢性骨髓增殖性肿瘤。临床表现为多血质、高血压、脾脏肿大、血栓形成及出血倾向。早期不易发现,以溶血为初发症状的较为罕见,现报告我院近期收治的1例真性红细胞增多症合并溶血患者的临床资料,并复习相关资料予以讨论。
作者 蔡守兵 于亮
出处 《中国现代医药杂志》 2011年第8期94-95,共2页 Modern Medicine Journal of China
  • 相关文献

参考文献7

  • 1Spivak JL.Polycythemia vera : myths, mechanisms, and manageme- nt. Blood, 2002,100 ( 13 ) : 4272-4290.
  • 2白雯,王黎明,赵薇.克林霉素致免疫性溶血性贫血1例[J].第四军医大学学报,2007,28(10):934-934. 被引量:5
  • 3Phekoo KJ, Richards MA, Moiler H,et al :The incidence and out- come of myeloid malignancies in 2,112 adult patients in South East-England.Haematologica 2006,91 : 1400-1404.
  • 4张旭霞,李红玲.克林霉素致急性溶血性贫血[J].药物不良反应杂志,2008,10(2):142-143. 被引量:11
  • 5Zhao RX,Xing S,Li Z,et al.Identification of an Acquired JAK2 Mutation in Polycythemia Vera.J Biol Chem,2005,280 (24): 22788-22792.
  • 6Tefferi A, Lasho TL, Schwager SM, et al.The Clinical Phenotype of Wild-Type, Heterozygous, and Homozygous TAK2V617F in Poly- cythemia Vera.Cancer, 2006,106 (3) : 631-635.
  • 7Walz C ,Crowley BJ,Hudon HE,et al.Activated JAK2 with V617F Point Mutation Promotes G1/S.Phase Transition.J Biol Chem, 2006,281 (26) : 18177-18183.

二级参考文献4

共引文献14

同被引文献19

  • 1蒋开明.红细胞去除术治疗真性红细胞增多症的效果观察与护理[J].当代护士(中旬刊),2006,13(9):34-35. 被引量:7
  • 2杜俊英,徐晶,刘静华.真红细胞增多症静脉放血的护理[J].中国实用医药,2007,2(7):120-121. 被引量:4
  • 3陈卉.利用血浆分离器行红细胞分离术治疗真性红细胞增多症的护理[J].哈尔滨医药,2006,26(3):79-80. 被引量:2
  • 4Prchal JF, Axelrad AA. Letter: Bone-marrow responses in poly- cythemia vera[J]. N Engl J Med, 1974,290:1382.
  • 5Berk PD, Goldberg JD, Silverstein MN, et al. Increased incidence of acute leukemia vera associated with chlorambucil therapy [J]. N Engl J Med, 1981,30(4):441.
  • 6宋团月,陈春光.填性红细胞增多症引起ST段抬高1例报告[J].福建医科大学学报,1983,(02):126-127.
  • 7Gruppo Italiano Studio Policithemial. Polycythemia vera: the natural history of 1213 patients followed for 20 years [J]. Ann Intern Med, 1995,123(9):656- 6641.
  • 8Wumcunill J, Vaquer P, Glam A, et al. In hereditary hemoc hromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebot omy[J]. J Clinical Apheresis, 2002,17(2):88.
  • 9Berk PD, Wasserman LR, Fruchtman SM, et all Polycythemia vera and the Myeloproliferative Disordersl [M]. Philadelphia: WB aunders, 1995:166-1941.
  • 10Fruchtman SM, Mack K, Kaplan ME, et al. From efficacy to safety: a Polycythemia Vera Study Group report on hydroxyurea in patients with polycythemia vera[J]. Semin H ematol, 1997, 34(1 ): 17-23.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部